South Sudan vs Togo: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
South Sudan
1.7%
in 2024
Togo
1.4%
in 2024
South Sudan rank
20th
Togo rank
22nd
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- South Sudan
- Togo
How they compare
South Sudan currently reports 1.7% against 1.4% in Togo, a difference of 0.3%.
That makes South Sudan's figure about 1.2 times Togo's.
Across all 10 years both countries report, South Sudan has been ahead every year.
South Sudan ranks 20th and Togo ranks 22nd of 246 countries.
South Sudan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | South Sudan | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 4.2% | 1.9% | 2.3% | South Sudan |
| 2020s | 2.2% | 1.5% | 0.7% | South Sudan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, South Sudan or Togo?
- South Sudan, at 1.7% against 1.4% in Togo as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between South Sudan and Togo?
- 0.3%, with South Sudan ahead.
- How many years of comparable data are there for South Sudan and Togo?
- 10 years are reported by both, from 2015 to 2024.
- How do South Sudan and Togo rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- South Sudan ranks 20th and Togo ranks 22nd of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.